Literature DB >> 7582699

Aetiology and presenting symptoms in male osteoporosis.

P Peris1, N Guañabens, A Monegal, X Suris, L Alvarez, M J Martinez de Osaba, M V Hernandez, J Muñoz-Gomez.   

Abstract

In order to analyse the clinical characteristics and the principal causes of osteoporosis in men, 81 osteoporotic males from an out-patient rheumatology department were studied. Bone mass assessment, automated biochemical profile and biochemical markers of bone turnover were performed in all patients, and hormonal measurements were taken when a specific aetiology was not readily apparent. Sixty-three men (78%) had secondary osteoporosis and 18 (22%) primary osteoporosis. Secondary causes of osteoporosis included hypogonadism (12 patients), corticosteroid therapy (10 patients) and alcoholism (10 patients); the remaining patients had various causes of osteoporosis. Eighteen patients had primary osteoporosis, eight of them with associated hypercalciuria. Normocalciuric patients showed lower 25-hydroxyvitamin D and 1-25-hydroxyvitamin D levels than the control group, whereas hypercalciuric patients had lower parathyroid hormone and renal threshold for phosphate excretion. In 69 patients (85%), back pain was the chief complaint. Forty-five of these 69 patients (65%) had chronic back pain and 24 (35%) had subacute episodes. Fifty per cent of the patients with chronic back pain had vertebral fractures. Both patients with and without chronic back pain were found to have a similar number of vertebral fractures. In conclusion, male osteoporosis is frequently associated with major risk factors. Patients with primary osteoporosis may have associated hypercalciuria or decreased vitamin D levels. However, not all the patients for whom back pain was the chief complaint were found to have vertebral fractures.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582699     DOI: 10.1093/rheumatology/34.10.936

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  14 in total

1.  Alendronate and male osteoporosis.

Authors:  A Alkhenizan; S Almarri; M F Evans
Journal:  Can Fam Physician       Date:  2001-03       Impact factor: 3.275

2.  Guidelines on the management of osteoporosis associated with chronic liver disease.

Authors:  Jane D Collier; M Ninkovic; J E Compston
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

3.  The utility of BMD Z-score diagnostic thresholds for secondary causes of osteoporosis.

Authors:  F E McKiernan; R L Berg; J G Linneman
Journal:  Osteoporos Int       Date:  2010-06-09       Impact factor: 4.507

4.  Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density.

Authors:  A Cohen; R R Recker; J Lappe; D W Dempster; S Cremers; D J McMahon; E M Stein; J Fleischer; C J Rosen; H Rogers; R B Staron; J Lemaster; E Shane
Journal:  Osteoporos Int       Date:  2011-03-02       Impact factor: 4.507

5.  Vertebral fractures and bone mineral density in idiopathic, secondary and corticosteroid associated osteoporosis in men.

Authors:  S F Evans; M W Davie
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

Review 6.  Alcohol and bone: review of dose effects and mechanisms.

Authors:  D B Maurel; N Boisseau; C L Benhamou; C Jaffre
Journal:  Osteoporos Int       Date:  2011-09-17       Impact factor: 4.507

Review 7.  Current and potential future drug treatments for osteoporosis.

Authors:  S Patel
Journal:  Ann Rheum Dis       Date:  1996-10       Impact factor: 19.103

8.  Osteoporosis in men: the value of laboratory testing.

Authors:  C S Ryan; V I Petkov; R A Adler
Journal:  Osteoporos Int       Date:  2010-10-09       Impact factor: 4.507

Review 9.  Osteoporosis in men.

Authors:  Sundeep Khosla; Shreyasee Amin; Eric Orwoll
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

10.  Affective Disorders, Bone Metabolism, and Osteoporosis.

Authors:  Briana Mezuk
Journal:  Clin Rev Bone Miner Metab       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.